SCHEMBL6201906

SCHEMBL6201906

CCCc1cc(O)c2cc(C(=O)OCC)ccc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
L3MBTL1 Q9Y468 1/20 0.53
CA12 O43570 2/20 0.51
CA1 P00915 2/20 0.51
CA2 P00918 2/20 0.51
CA7 P43166 2/20 0.51
CA9 Q16790 2/20 0.51
CA14 Q9ULX7 2/20 0.51
NPC1 O15118 4/20 0.51
RAB9A P51151 4/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
KDM4E B2RXH2 4/20 0.50
HPGD P15428 2/20 0.50
HSD17B10 Q99714 1/20 0.50
SMN1; SMN2 Q16637 3/20 0.49
MEN1 O00255 1/20 0.47
BLM P54132 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6203321 0.85 HSD17B2 (0.51) ALDH1A1L3MBTL1NPC1RAB9ACYP1A2
SCHEMBL538292 0.84 ALDH1A1 (0.57) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL9907539 0.77 ALDH1A1 (0.60) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL9180764 0.77 GAA (0.48) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL9070470 0.76 CA12 (0.56) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL9709715 0.75 ALDH1A1 (0.57) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL24426144 0.75 ALDH1A1 (0.63) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL10957210 0.75 CA12 (0.59) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL9907605 0.74 ALDH1A1 (0.66) ALDH1A1L3MBTL1CA12CA1CA2
SCHEMBL9907331 0.74 ALDH1A1 (0.59) ALDH1A1L3MBTL1NPC1RAB9ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1451156-A4 4-AMINOQUINOLINE COMPOUNDS MERCK & CO INC (US) 2005-05-25 EP disclosed
US-20050009815-A1 4-Aminoquinoline compounds DEVITA ROBERT J (US) 2005-01-13 US disclosed
EP-1451156-A1 4-AMINOQUINOLINE COMPOUNDS Merck & Co., Inc. (US) 2004-09-01 EP disclosed
WO-2003045920-A1 4-AMINOQUINOLINE COMPOUNDS MERCK & CO., INC. (US) 2003-06-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009815-A1 4-Aminoquinoline compounds MCHR1, MCHR2, MC5R ALDH1A1 364/4885L3MBTL1 3092/4885CA12 4755/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.